• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$1.70 $0.02 (1.19%)

REAL-TIME: Last trade at

RESPONSE GENETICS, INC.

NASDAQ:RGDX

Jump to this page for:

Related Resources

Response Genetics, Inc. Announces First Quarter Financial Results

5/10/2012 by PharmiWeb.com - UK

Response Genetics, Inc. (RGDX) Bests Q1 Loss Views by 9c/Share

5/10/2012 by StreetInsider.com

Response Genetics reports Q1 EPS (14c), one estimate (10c)

5/10/2012 by Theflyonthewall.com

Response Genetics, Inc. Announces First Quarter Financial Results

5/10/2012 by Business Wire

Response Genetics files to sell 5.26M shares of common stock for holders

4/30/2012 by Theflyonthewall.com

Response Genetics (RGDX) Files 5.26M Common Shelf for Shareholders

4/30/2012 by StreetInsider.com

Global Genetic Testing Industry

4/16/2012 by PR Newswire

UPDATE: Response Genetics' Q4 Revenues Slide 23 Percent as Project Nears End

3/28/2012 by GenomeWeb

Falling Revenue Hurts Response Genetics’ Quarter

3/27/2012 by Los Angeles Business Journal - Los Angeles CA

Response Genetics' Q4 Revenues Slide 23 Percent as Work for GSK Ends

3/27/2012 by GenomeWeb

Response Genetics, Inc. (RGDX) Posts Q4 Loss of 21c/Share, Wider than Views

3/27/2012 by StreetInsider.com

Response Genetics reports Q4 EPS (21c), one estimate (4c)

3/27/2012 by Theflyonthewall.com

Response Genetics, Inc. Announces Year-End and Fourth Quarter Financial Results

3/27/2012 by Business Wire

Response Genetics, Inc. Announces Appointment of Stephanie Astrow, Ph.D., as Vice President, Research and Development

3/26/2012 by Genetic Engineering News

Response Genetics, Inc. Announces Appointment of Stephanie Astrow, Ph.D., as Vice President, Research and Development

3/26/2012 by Business Wire

Response Genetics, Inc. to Release Fourth Quarter and Full-Year 2011 Financial Results and Host Conference Call on March 27, 2012

3/21/2012 by PharmiWeb.com - UK

Response Genetics, Inc. to Release Fourth Quarter and Full-Year 2011 Financial Results and Host Conference Call on March 27, 2012

3/21/2012 by Business Wire

Report says genetic test spending could hit $25B by 2021, LA Times says

3/12/2012 by Theflyonthewall.com

Response Genetics Regains NASDAQ Compliance

2/21/2012 by PharmiWeb.com - UK

Response Genetics Regains NASDAQ Compliance

2/21/2012 by Business Wire

Response Genetics: This Train Is About To Leave The Station

2/16/2012 by Seeking Alpha

Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference

2/6/2012 by Genetic Engineering News

Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference

2/6/2012 by Business Wire

Response Genetics raises $7.8 million in stock sale

2/3/2012 by Los Angeles Business - Los Angeles CA

Response Genetics Stock Soars 31% On $7.8M Offering News

2/3/2012 by Seeking Alpha

Response Genetics Makes Private Placement

2/2/2012 by Los Angeles Business Journal - Los Angeles CA

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

2/2/2012 by 24/7 Wall Street

Response Genetics Raises $7.8M in Financing

2/2/2012 by IVD Technology

Morning Movers (GMCR, GPS, RGDX, EDMC, SD)

2/2/2012 by 24/7 Wall Street

Response Genetics raises $7.8M in financing

2/2/2012 by Theflyonthewall.com

Response Genetics Raises More Than $7.8 Million in Financing

2/2/2012 by Business Wire

Response Genetics names new CEO

12/23/2011 by Los Angeles Business - Los Angeles CA

Response Genetics Selects CEO

12/22/2011 by Los Angeles Business Journal - Los Angeles CA

Response Genetics Names Thomas A. Bologna Chairman and CEO

12/22/2011 by PharmiWeb.com - UK

Response Genetics (RGDX) Appoints Tom Bologna as CEO

12/22/2011 by StreetInsider.com

Response Genetics names Thomas Bologna CEO

12/22/2011 by Theflyonthewall.com

Response Genetics Names Thomas A. Bologna Chairman and CEO

12/22/2011 by Business Wire

Response Genetics Test Target Patients That Xalkori Can Help

12/21/2011 by NASDAQ

Response Genetics (RGDX) Introduces New ALK Testing Capabilities for NSCLC Tumors

12/21/2011 by StreetInsider.com

Response Genetics, Inc. to Offer FDA-Approved ALK Test for metastatic NSCLC

12/21/2011 by StockWatch
See More Articles...